We partner with sponsors to advance programs from early development through late-stage trials with hands-on leadership, inspection-ready execution, and the operational rigor required to meet GCP, ICH, and global regulatory expectations.
ClinicalDevelopment, ClinicalOperations, StrategicAdvisory, and BiotechConsulting tailored to your portfolio.
We partner with sponsors to advance programs from early development through late-stage trials with hands-on leadership, inspection-ready execution, and the operational rigor required to meet GCP, ICH, and global regulatory expectations.
Global site start-up, enrollment acceleration, and CRO coordination.
Go-to-clinic strategy, portfolio prioritization, and due diligence.
Operating models that scale from seed to post-IPO.
EarlyclinicalDevelopment through GlobalClinicalTrials with InspectionReadiness and BIMO at the core.
Translational strategy, FIH protocol, and safety/pharmacology frameworks.
Country selection, site networks, and adaptive enrollment management.
Mock inspections, storyboards, and TMF excellence ahead of HA audits.
Robust processes aligning with FDA BIMO expectations and GCP.
Right-sized SOPs, audit readiness, and BIMO-aligned processes for consistent compliance.
Lean governance, dashboards, and continuous improvement across study delivery.
Accountable leadership across cross-functional teams—medical, safety, stats, and operations.
PatientCentric • scalableClinicalOperations • decisionReadyData
eConsent, decentralized options, and burden-reducing schedules.
Playbooks and templates accelerating study start-up and execution.
Real-time dashboards, risk-based monitoring, and clean locks on time.
Get a practical roadmap to GCP-compliant, inspection-ready trials.
Contact UsCoteClinical Advisors • 94403 • Global